secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0001558370-24-004842
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health appoints Scott J. Saunders as independent director to fill vacancy
-------------------------------------------------------------------------------

- Scott J. Saunders, age 61, appointed to Board effective April 11, 2024, replacing deceased director John Waters.
- Board determined Saunders is independent under Nasdaq standards; term expires at 2024 Annual Meeting.
- Saunders receives standard non-employee director compensation: $150,000 per year in monthly installments.
- Saunders is Managing Director at Farlie Turner Gilbert, healthcare M&A advisor, with 30+ years in middle-market advisory.
- No family relationships or material interests between Saunders and company officers under Reg S-K Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004842/0001558370-24-004842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000155837024004842/nutx-20240408x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-004842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer